{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T05:05:32Z","timestamp":1774155932869,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jchromb.2024.124187","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:35:44Z","timestamp":1718411744000},"page":"124187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Semaglutide and health risk: Development and validation of a LC-HRMS method for testing semaglutide in whole blood and application to real cases"],"prefix":"10.1016","volume":"1242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6676-1406","authenticated-orcid":false,"given":"N.","family":"Arbouche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3110-2168","authenticated-orcid":false,"given":"A.","family":"Blanchot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Raul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kintz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124187_b0005","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s13300-020-00894-y","article-title":"A review on Semaglutide: an oral glucagon-like peptide 1 receptor agonist in management of type 2 diabetes mellitus","volume":"11","author":"Kalra","year":"2020","journal-title":"Diabetes Ther."},{"issue":"12","key":"10.1016\/j.jchromb.2024.124187_b0010","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s40262-018-0668-z","article-title":"Pharmacokinetics and clinical implications of semaglutide: a new glucagon-like peptide (GLP)-1 receptor agonist","volume":"57","author":"Hall","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2024.124187_b0015","unstructured":"OZEMPIC (semaglutide) injection, for subcutaneous use, 2017. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209637lbl.pdf (Accessed January 2024)."},{"key":"10.1016\/j.jchromb.2024.124187_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-023-01233-4","article-title":"Pharmacotherapy for obesity: moving towards efficacy improvement","volume":"16","author":"Coutinho","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"issue":"18","key":"10.1016\/j.jchromb.2024.124187_b0025","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1080\/14656566.2023.2271389","article-title":"Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward","volume":"24","author":"Chiappini","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jchromb.2024.124187_b0030","unstructured":"ANSM, Ozempic (s\u00e9maglutide): un m\u00e9dicament \u00e0 utiliser uniquement dans le traitement du diab\u00e8te de type 2, 2023. https:\/\/ansm.sante.fr\/actualites\/ozempic-semaglutide-un-medicament-a-utiliser-uniquement-dans-le-traitement-du-diabete-de-type-2 (Accessed on 08 January 2024)."},{"key":"10.1016\/j.jchromb.2024.124187_b0035","unstructured":"Le Monde, 2023. https:\/\/www.lemonde.fr\/societe\/article\/2023\/03\/02\/alerte-sur-l-ozempic-un-antidiabetique-detourne-pour-perdre-du-poids_6163816_3224.html (Accessed on 08 January 2024)."},{"key":"10.1016\/j.jchromb.2024.124187_b0040","doi-asserted-by":"crossref","unstructured":"In brief: GI effects of GLP-1 receptor agonists, Med. Lett. Drugs Ther. 65(1690) (2023) 191\u2013192.","DOI":"10.58347\/tml.2023.1690e"},{"key":"10.1016\/j.jchromb.2024.124187_b0045","unstructured":"The Independent, 2023. https:\/\/www.independent.co.uk\/news\/world\/americas\/australia-woman-dies-ozempic-weight-loss-b2445052.html (Accessed 09 January 2024)."},{"key":"10.1016\/j.jchromb.2024.124187_b0050","unstructured":"The Daily Mail, 2023. https:\/\/www.dailymail.co.uk\/health\/article-12571045\/ozempic-wegovy-semaglutide-effect-weight-loss-ileus-fda.html (Accessed 09 January 2024)."},{"issue":"5","key":"10.1016\/j.jchromb.2024.124187_b0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jcph.443","article-title":"Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol\/levonorgestrel","volume":"55","author":"Kapitza","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2024.124187_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123688","article-title":"Novel LC-MS\/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies in rats","author":"Lee","year":"2023","journal-title":"J. Chrom. B"},{"issue":"7","key":"10.1016\/j.jchromb.2024.124187_b0065","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1515\/cclm-2022-1316","article-title":"Simultaneous analysis of antihyperglycemic small molecule drugs and peptide drugs by means of dual liquid chromatography high-resolution mass spectrometry","volume":"61","author":"Vollmer","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2024.124187_b0070","first-page":"1","article-title":"Help for validation of analytical procedures in toxicology and therapeutic drug monitoring","volume":"17","author":"Digeon","year":"2005","journal-title":"Ann Toxicol Anal."},{"key":"10.1016\/j.jchromb.2024.124187_b0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchromb.2018.05.020","article-title":"Determination of liraglutide in rat plasma by a selective liquid chromatography-tandem mass spectrometry method: Application to a pharmacokinetics study","volume":"1091","author":"Dong","year":"2018","journal-title":"J. Chrom. B"},{"key":"10.1016\/j.jchromb.2024.124187_b0080","series-title":"Biomaterials Science","first-page":"645","article-title":"Asorbed proteins on biomaterials","author":"Horbett","year":"2020"},{"issue":"9","key":"10.1016\/j.jchromb.2024.124187_b0085","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1093\/jat\/bkac094","article-title":"Influence of preservatives on insulin in postmortem blood: application to a case of insulin aspart suicide","volume":"46","author":"Arbouche","year":"2023","journal-title":"J. Anal. Toxicol."},{"issue":"23","key":"10.1016\/j.jchromb.2024.124187_b0090","doi-asserted-by":"crossref","first-page":"8937","DOI":"10.1021\/ac201540t","article-title":"Strategy and its implications of protein bioanalysis utilizing high-resolution mass spectrometric detection of intact protein","volume":"83","author":"Ruan","year":"2011","journal-title":"Anal. Chem."},{"issue":"104","key":"10.1016\/j.jchromb.2024.124187_b0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2017.03.020","article-title":"Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species","volume":"15","author":"Jensen","year":"2017","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322400196X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322400196X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T18:39:37Z","timestamp":1720031977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322400196X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":19,"alternative-id":["S157002322400196X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124187","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaglutide and health risk: Development and validation of a LC-HRMS method for testing semaglutide in whole blood and application to real cases","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124187"}}